Emles @Home ETF
LIV
LIV was delisted on the 19th of October, 2022.
2 hedge funds and large institutions have $3.84M invested in Emles @Home ETF in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $3.92M → $3.84M (-$85K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.53K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $3.83M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | -$3.53K | -133 | -83% |
|
LIV Hedge Fund Activity: Q1 2021 in Review
2 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Emles @Home ETF (LIV) for Q1 2021, worth a combined $3.84M — down 2.2% from $3.92M a quarter earlier.
Fund positioning in LIV was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $3.53K.
- 2 institutional investors held Emles @Home ETF (LIV) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $3.84M of Emles @Home ETF stock for Q1 2021, down 2.2% quarter-over-quarter.
- 0 funds opened new Emles @Home ETF positions in Q1 2021 and 0 closed out.
- The largest Emles @Home ETF seller in Q1 2021 was UBS Group, an estimated $3.53K sold.
Based on aggregated 13F filings for Q1 2021.